One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors
Authors:
- Toshihiro KitaTKToshihiro Kita
- Naoto YokotaNYNaoto Yokota
- Yoshinari IchikiYIYoshinari Ichiki
- Takao AyabeTATakao Ayabe
- Takuma EtohTETakuma Etoh
- Noboru TamakiNTNoboru Tamaki
- Johji KatoJKJohji Kato
- Tanenao EtoTETanenao Eto
- Kazuo KitamuraKKKazuo Kitamura
- 15 January 2010
- journal article
- clinical trial
- Published by Springer Nature in Hypertension Research
- Vol. 33 (4) , 320-325
Abstract
The long-term antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ) combinations have not been appropriately evaluated in Japan. In this study, treated hypertensive patients taking angiotensin-receptor blocker (ARB) or angiotensin-converting enzyme inhibitor (ACEI) regimens not at blood pressure (BP) goals proposed by the Japanese Society of Hypertension (JSH) were switched to losartan/HCTZ combinations and followed for 1 year. Data analysis included 244 patients aged 64.5+/-10.7 years, 56% male, 27% with diabetes mellitus and 36% with dyslipidemia. Pre-switching BP 157+/-16/88+/-10 mm Hg promptly decreased and maintained a steady state, reaching 132+/-15/77+/-9 mm Hg (P/=7.0 mg dl(-1)). Losartan/HCTZ combinations showed strong and steady hypotensive abilities and acceptable safety and tolerability in patients currently not at BP goals with regimens including ARBs or ACEIs in Japan.Keywords
This publication has 19 references indexed in Scilit:
- The relationship between antihypertensive combination therapies comprising diuretics and/or β-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort studyHypertension Research, 2009
- Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patientsHypertension Research, 2009
- Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in HumansJournal of Biological Chemistry, 2008
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential HypertensionHypertension Research, 2007
- Concentration-Dependent Mode of Interaction of Angiotensin II Receptor Blockers with Uric Acid TransporterThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/AmlodipineHypertension Research, 2007
- Current Usage of Diuretics among Hypertensive Patients in Japan: The Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) StudyHypertension Research, 2006
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Molecular identification of a renal urate–anion exchanger that regulates blood urate levelsNature, 2002